Article
Disease modification upon brief exposure to tofacitinib during chronic epilepsy
2023-08-08
Abstract excerpt
<h4>ABSTRACT</h4> All current drug treatments for epilepsy, a neurological disorder affecting over 50 million people( 1, 2 ) merely treat symptoms, and a third of patients do not respond to medication. There are no disease modifying treatments that may be administered briefly to patients to enduringly eliminate spontaneous seizures and reverse cognitive deficits( 3, 4 ). Applying network approaches to rodent mo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a3def665-79f2-5959-987f-6473d7b636ab
- DOI
- 10.1101/2023.08.07.552299
